On the compassionate use of UK101 in metastatic cancer

Journal of Tumor Marker Oncology

Volumn 12, Issue 1, 1997, Pages 29-37

  Mor, C ^a   Gariboldi, A ^b   Bissi, O ^a   Concas Benevelli, D ^c   Di Mattia, D ^a   Gajani, M R ^a   Gilardoni, E ^a   Liverani, A ^b   Mancini, S ^a   Santi, C ^a   Bartorelli, A ^b,d  

^a Ospedale Uboldo   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SICOR SpA   (Italy)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010747462     PISSN: 08863849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bartorelli A.: Free CEA binding substance in cancer sera. Biomedical Pharmacotherapy 41, 2-5, (1987).
2. Bartorelli A, Berra B, Ronchi S, Biancardi C, Cavalca V, Bailo M, Mor C, Ferrara R, Botta M, Arzani C, Clemente C: Immunocytochemical reactivity of mammalian liver antigen (UK101) in human tumors and non neoplastic tissues. Journal of Tumor Marker Oncology 9:3, 37-47, (1994).
3. Bartorelli A., Biancardi C., Bailo M., Botta M., Cavalca V., Ferrara R., Arzani C.:UK101 from Mammalian cells: a New Tool in Cancer Therapy. Abstract of the 12th International Conference on Human Tumor Markers, New York, June 11-14, 1995. Journal Tumor Marker Oncology 10:2, 56, (1995).
4. Bartorelli A, Bussolati B, Millesimo M, Gugliotta P, Bussolati G: Antibody-dependent cytotoxic activity on human cancer cells expressing UK114 tumor membrane antigen, International Journal Oncology 8, 543-548, (1996).
5. Bussolati G, Clemente C.: Light and electron microscopical localization of UK114-related antigen in normal neoplastic tissues. Abstract of the 12th International Conference on Human Tumor Markers, New York, June 11-14, 1995. Journal Tumor Marker Oncology 10:2, 57-58, (1995).
6. Cavallo F, Consalvo M, Millesimo M, Gillio Tos A. and Forni G: Anti-tumor activity of UK114 in mice. Abstract of the 12th International Conference on Human Tumor Markers, New York, June 11-14, 1995. Journal of Tumor Marker Oncology 10:3, 59, (1995).
7. Ceciliani R, Faotto L, Negri A., Colombo I., Berra B., Bartorelli A., Ronchi S.: The primary structure of UK114 tumor antigen. Febs Letters 393, 147-150, (1996).
8. Bartorelli A, Zanolo G, Fassio F, Botta M, Ferrara R, Bailo M, Biancardi C, Cavalca V, Arzani C, Maraschin R: Toxicological and anti-tumoral activity of UK101, a mammalian liver extract. Journal of Tumor Marker Oncology 9:3, 49-56, (1994).
9. Bartorelli A, Berra B, Clemente C, Liverani A, Santi C, Ronchi S, Botturi M, Corchia PL, Orefice S, Mor C: Preliminary results of the use of UK101 for compassionate reasons in advanced cancer patients. Journal of Tumor Marker Oncology 9:3, 57-64, (1994).
10. Bartorelli A, Biancardi C, Cavalca V, Clemente C, Ferrara R, Arzani C, Bailo M, Botta M: Enzyme-linked immunosorbent assays /ELISA) for the detection of antibodies to UK114 and UK150. Journal of Tumor Marker Oncology 11:1, 67-80, (1996).
11. Mor C, Bissi O, Di Mattia D, Gariboldi A, Liverani A, Mancini S, Santi C: UK101 first clinical report". Abstract of the 12th International Conference on Human Tumor Markers, New York, June 11-14, 1995. J. Tumor Marker Oncology 10:2, 59-60, (1995).
12. Greenway B., Hepatic metastases from colorectal cancer: Resection or not. BR. J. Surg. 210, 513-519, (1988).
13. Logan S.M., Meier S. J., Ramming K. P., Motion D. L., Longmire W. P. Hepatic resection of metastatic colorectal carcinoma. Arch. Surg. 117, 25-28, (1982).
14. Wagner J.S., Adson M.A., Van Heerden J.A., Adson M.M., Estrup D. M., The natural history of hepatic metastases from colorectal cancer. Ann. Surg. 199, 502-508, (1984).